Investing in justice: Ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis

Theodore C. Bailey, Maria W. Merritt, Fabrizio Tediosi

Research output: Contribution to journalArticlepeer-review

Abstract

It has been suggested that initiatives to eradicate specific communicable diseases need to be informed by eradication investment cases to assess the feasibility, costs, and consequences of eradication compared with elimination or control. A methodological challenge of eradication investment cases is how to account for the ethical importance of the benefits, burdens, and distributions thereof that are salient in people's experiences of the diseases and related interventions but are not assessed in traditional approaches to health and economic evaluation. We have offered a method of ethical analysis grounded in theories of social justice. We have described the method and its philosophical rationale and illustrated its use in application to eradication investment cases for lymphatic filariasis and onchocerciasis, 2 neglected tropical diseases that are candidates for eradication.

Original languageEnglish (US)
Pages (from-to)629-636
Number of pages8
JournalAmerican journal of public health
Volume105
Issue number4
DOIs
StatePublished - Apr 1 2015

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Investing in justice: Ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis'. Together they form a unique fingerprint.

Cite this